Human pluripotent stem cell (PSC) technology and direct somatic cell reprogramming have opened up a promising new avenue in the field of neuroscience. These recent advances allow researchers to obtain virtually any cell type found in the human brain, making it possible to produce and study functional neurons in laboratory ⁎⁎ Corresponding author at: Institute of Human Genetics, Julius-Maximilians-University Wuerzburg, Biozentrum, Am Hubland, 97074, Wuerzburg, Germany.
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